Stockhead on MSN
Health check: Imricor shares soar on the heart device play’s second FDA clearance this month
Two weeks after giving the nod to Imricor's novel ablation catheter, the FDA has cleared the company's overriding 'dashboard' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results